Abstract: Disclosed herein is a composite material that is formed from a polymer, acetylated collagen and graphene, which can be used as a super-capacitor material. Also disclosed herein are methods of making said composite material and its intermediates, as well as a supercapacitor made using said material.
Type:
Grant
Filed:
December 7, 2017
Date of Patent:
July 11, 2023
Assignees:
COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (CSIR), JOHN KEELLS HOLDINGS PLC
Abstract: The present invention relates to a porous ABPBI (phosphoric acid doped poly (2, 5-benzimidazole)) membrane and process of preparing the same. A stable porous ABPBI (Phosphoric Acid Doped Poly (2, 5-benzimidazole)) membrane stable to acids, bases, solvents and autoclaving is disclosed. The membrane finds use for separation of solutes in solution in acids, bases and solvents.
Type:
Grant
Filed:
March 24, 2014
Date of Patent:
September 12, 2017
Assignee:
COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (CSIR)
Abstract: The present invention relates to a pharmaceutical composition for preventing and/or treating dementia comprising extracts of Monsonia sp.; a food composition for preventing and/or improving dementia comprising extracts of Monsonia sp.; and a method of preparing an extract of Monsonia sp. with excellent inhibitory effect on the formation of ?-amyloid. The plant extract can inhibit the formation of ?-amyloid which has been known as a factor causing the dementia, especially Alzheimer's disease, thereby being used for preventing, improving and/or treating the dementia.
Type:
Application
Filed:
September 26, 2013
Publication date:
March 27, 2014
Applicants:
COUNCIL FOR SCIENTIFIC AND INDUSTRIAL RESEARCH (CSIR), KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
Inventors:
Hyun Ok YANG, Sung-Kwon CHUNG, Hak Cheol KWON, Jin Wook CHA, Vinesh Jaichand MAHARAJ, Rudzani NTHAMBELENI, Dashnie NAIDOO, Young-Joo KIM, Jungyeob HAM, Jeremiah SENABE, Gerda FOUCHE, Eric KHOROMBI, Joon Ki KIM
Abstract: The invention provides a novel herbal composition for treatment of arthritis and inflammation. The herbal composition comprises a therapeutically effective combination of extracts obtained from the plants Terminalia chebula, Pluchea lanceolata, Desmodium gangeticum, Vitex negunto and Zingiber officinale, optionally along with pharmaceutically acceptable additives. The invention further comprises methods of making the herbal composition and methods of use for the treatment of arthritis and inflammation.
Type:
Application
Filed:
January 24, 2008
Publication date:
May 22, 2008
Applicant:
Council of Scientific & Industrial Research (CSIR)
Abstract: A process to identify peptide antagonists of Hsp16.3, a chaperon protein necessary for the survival of Mycobacterium tuberculosis in the dormant phase is described. Affinity selection of a 7-mer and a 12-mer random peptide libraries displayed on bacteriophage M13 was performed using recombinant Hsp16.3 as template and two peptide phage clones, which bind to the Hsp16.3 protein were identified. Synthetic peptides corresponding to the peptide sequences displayed on these phage clones were able to specifically bind and inhibit the chaperone function of Hsp16.3 in vitro in a dose dependent manner. The corresponding inhibitory effect of these peptides on the chaperon activity of alphaB-crystallin, a constituent of human eye lens and a homologue of Hsp16.3, was found to be substantially less. These peptide inhibitors, or similar inhibitors generated by the process described, which specifically target Hsp16.3, can hence be used as lead compounds to obtain better therapeutics against latent tuberculosis.
Type:
Application
Filed:
May 26, 2004
Publication date:
February 15, 2007
Applicant:
Council of Scientific and Industrial Research (CSIR)
Abstract: The present invention relates to a method of detection of predisposition to emphysema in chronic obstructive pulmonary disease (COPD). It particularly relates with the regulation of the key molecular and biochemical components of the pathway leading to the manifestation of emphysema in COPD.
Type:
Application
Filed:
December 2, 2004
Publication date:
August 10, 2006
Applicant:
COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (CSIR)
Abstract: The present Application relates to a process for the preparation of ultrafiltration membranes from polyacrylonitrile using malic acid as additives, with said membrane of molecular weight ranging between 80 to 180K, showing high purification and water permeating ability.
Type:
Grant
Filed:
August 30, 2002
Date of Patent:
February 22, 2005
Assignee:
Council of Scientific & Industrial Research (CSIR)
Abstract: The present invention provides a novel strain of Streptomyces sp. Having Accession Number PTA 973 and a process for the preparation of an alkaline protease inhibitor employing the said strain.
Type:
Application
Filed:
February 3, 2003
Publication date:
February 26, 2004
Applicant:
Council for Scientific and Industrial Research (CSIR)
Abstract: The present invention provides a novel strain of Streptomyces sp. having Accession Number PTA 973 and a process for the preparation of an alkaline protease inhibitor employing the said strain.
Type:
Application
Filed:
February 3, 2003
Publication date:
July 24, 2003
Applicant:
Council for Scientific and Industrial Research (CSIR)
Abstract: The present invention relates to a process for the preparation of refined hard sugarcane wax having improved qualities from press mud which comprises digesting press mud with a non polar solvent in the presence of activated charcoal and separating the sugarcane wax from the residue.
Type:
Grant
Filed:
March 31, 1998
Date of Patent:
November 26, 2002
Assignee:
Council of Scientific & Industrial Research (CSIR)